New liquid biopsy could replace painful biopsies for bladder cancer patients
NCT ID NCT07441499
First seen Mar 08, 2026 · Last updated May 25, 2026 · Updated 10 times
Summary
This study tests whether a simple blood and urine test (liquid biopsy) can help diagnose, monitor treatment response, and predict recurrence in people with urothelial carcinoma (a type of bladder cancer). Researchers will compare these non-invasive tests to standard tissue biopsies in 300 participants. The goal is to find a safer, easier way to track cancer over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The second hospital of Tianjin Medical University
RECRUITINGTianjin, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.